1. Protocols for Weaning and De-escalating Antidote Infusions

As clinical toxicity resolves, predefined clinical and laboratory endpoints must guide the safe tapering and discontinuation of pharmacologic and decontamination measures. This structured approach minimizes the risk of rebound toxicity and ensures patient safety.

1.1 Clinical and Laboratory Criteria for Discontinuation

A combination of clinical stability and reassuring laboratory markers is required before stopping any antidote infusion.

• Hemodynamic Stability: Heart rate 60–100 bpm; blood pressure within the patient’s baseline range without vasopressor support.
• Neurologic Recovery: Return to baseline mental status without the influence of sedatives; stable Glasgow Coma Scale (GCS).
• Respiratory Adequacy: FiO₂ < 0.4 and PaO₂/FiO₂ ratio > 200, with no anticipated need for re-intubation.
• Laboratory Markers: Toxin concentration below the toxic threshold or undetectable, closure of the anion gap, normalization of pH, and a clear downward trend of organ-specific injury markers (e.g., AST/ALT for hepatotoxicity).

1.2 Stepwise Tapering Schedules for Antidote Infusions

1.3 Criteria for Discontinuing GI Decontamination

Decontamination measures should be guided by toxin kinetics and patient status, not fixed timeframes.

2. Intravenous to Enteral Antidote Regimen Conversion

Transitioning from IV to enteral therapy is a key step toward ICU discharge. This process requires careful consideration of pharmacokinetics, GI function, and monitoring to ensure therapeutic equivalence and patient safety.

2.1 Pharmacokinetic Considerations

• Bioavailability: The fraction of an oral dose that reaches systemic circulation can vary dramatically. For example, oral N-acetylcysteine (NAC) has a bioavailability of only 6–10%, requiring much higher doses than IV NAC to achieve similar systemic exposure.
• First-Pass Metabolism: Drugs that are heavily metabolized by the liver after absorption may have reduced efficacy when given enterally, necessitating dose adjustments.
• GI Function: The patient must have adequate GI motility and absorption. The presence of an ileus, vomiting, or malabsorption syndromes are contraindications to enteral conversion.

2.2 Management of Enteral Access Devices (NGT, PEG)

Proper management of feeding tubes is critical to ensure accurate drug delivery.

• Flushing: Flush tubes with at least 30 mL of water before and after each medication administration to ensure patency and prevent drug interactions within the tube.
• Formulations: Use liquid or immediate-release formulations whenever possible. Never crush extended-release or enteric-coated tablets without consulting a pharmacist, as this can lead to dose dumping and toxicity.
• Feeding Schedules: Coordinate medication administration with enteral feeding schedules. Some drugs may require holding tube feeds for 1-2 hours before and after administration to optimize absorption.

3. Mitigating Post-ICU Syndrome and Long-Term Complications

Recovery from a critical poisoning extends beyond the resolution of acute toxicity. Proactive, multidisciplinary interventions are essential to reduce the significant physical, cognitive, and psychological sequelae known as Post-ICU Syndrome (PICS).

3.1 Identification of High-Risk Patients

Patients at high risk for PICS include those with:

• Prolonged mechanical ventilation (> 48–72 hours) or sedation (> 3 days).
• Exposure to high-risk medications like opioids, benzodiazepines, and antipsychotics.
• Pre-existing cognitive or psychiatric conditions.

3.2 Implementation of the ABCDEF Bundle

The ABCDEF bundle is a proven, evidence-based strategy to improve ICU outcomes, reduce delirium, and mitigate PICS.

4. Comprehensive Medication Reconciliation and Discharge Counseling

A structured handoff process and robust patient education are critical to reducing post-discharge medication errors and preventing the recurrence of poisoning.

4.1 Structured Reconciliation Process

A pharmacist-led medication reconciliation is the gold standard. The process should:

• Compile and compare pre-admission, in-hospital, and discharge medication lists.
• Clearly document all antidote taper schedules and required post-discharge monitoring.
• Highlight any high-risk medications (e.g., opioids, sedatives) and recent dose adjustments.

4.2 Patient and Caregiver Education

Use the “teach-back” method to ensure comprehension of key safety information:

• Safe Storage and Disposal: Emphasize the use of lockboxes for high-risk medications and provide information on local drug take-back programs for disposal of unused prescriptions.
• Recognizing Early Toxicity: Educate on key warning signs (e.g., excessive somnolence, respiratory changes, GI upset) and provide clear instructions on when to seek emergency care.
• Emergency Contacts: Provide the national Poison Control Center hotline (1-800-222-1222) and other emergency contact information.

4.3 Strategies to Prevent Recurrent Overdose

For intentional overdoses, discharge planning must include robust mental health support and harm reduction strategies:

• Enrollment in state prescription drug monitoring programs (PDMPs) to prevent “doctor shopping.”
• Referrals for behavioral interventions like motivational interviewing or Cognitive Behavioral Therapy (CBT).
• Limiting quantities of high-risk prescriptions and scheduling close outpatient follow-up within 7 days of discharge.

5. Handoff and Communication Strategies

Standardized communication tools and a culture of interprofessional collaboration are essential to ensure continuity of care and prevent information loss during transitions from the ICU to the ward and ultimately to home.

5.1 ICU-to-Ward Discharge Checklists

Use a standardized discharge checklist (paper or electronic) to ensure critical information is conveyed, including:

• Final diagnosis and details of the toxic exposure.
• Complete timeline of antidote infusions, including start/stop times and taper endpoints.
• A clear list of medications to continue, hold, or discontinue on the medical ward.
• Pending laboratory tests or consultations.

5.2 Interprofessional Collaboration and Documentation

Effective handoffs are a team sport. Foster collaboration through:

• Shared templates within the Electronic Health Record (EHR) for pharmacists, nurses, and physicians to document transition-of-care notes.
• Scheduled “warm handoffs” (in-person or via phone/video) between the ICU and ward teams to allow for questions and clarification.